This consultation closed on Tuesday, 30 March 2021.

The Therapeutic Goods Administration (TGA) sought to understand potential obstacles and incentives to repurposing of prescription medicines that may influence a sponsor's decision to extend an indication for an existing medicine. To assist in identifying potential regulatory and reimbursement policy options and further consultation may occur.

Enquiries

Any questions relating to submissions should be emailed to medicines.review@health.gov.au